Climb Bio (CLYM) Earnings Date, Estimates & Call Transcripts $1.27 -0.03 (-2.31%) As of 03/27/2025 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock Climb Bio Latest Earnings SummaryLatest Q4 2024 Earnings DateMar. 25EstimatedActual EPS (Mar. 25) -$0.13 Beat By $0.02 Consensus EPS (Mar. 25) -$0.15 Climb Bio announced Q4 2024 earnings on March 25, 2025, reporting an EPS of -$0.13, which topped the consensus estimate of -$0.15 by $0.02. With a trailing EPS of -$2.13, Climb Bio's earnings are expected to grow next year, from ($1.57) to ($0.66) per share. Get Climb Bio Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Climb Bio and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCLYM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CLYM Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Climb Bio Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.15-$0.15-$0.15Q2 20251-$0.16-$0.16-$0.16Q3 20251-$0.16-$0.16-$0.16Q4 20251-$0.17-$0.17-$0.17FY 20254($0.64)($0.64)($0.64) Remove Ads Climb Bio Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails3/25/2025Q4 2024-$0.15-$0.13+$0.02-$0.13--11/12/2024---$0.13 -$0.13-$0.13-- Climb Bio Earnings - Frequently Asked Questions When did Climb Bio announce their last quarterly earnings? Climb Bio (NASDAQ:CLYM) last announced its quarterly earning data on Tuesday, March 25, 2025. Learn more on CLYM's earnings history. Did Climb Bio beat their earnings estimates last quarter? In the previous quarter, Climb Bio (NASDAQ:CLYM) reported ($0.13) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.15) by $0.02. Learn more on analysts' earnings estimate vs. CLYM's actual earnings. How much profit does Climb Bio generate each year? Climb Bio (NASDAQ:CLYM) has a recorded net income of -$35.12 million. CLYM has generated -$2.13 earnings per share over the last four quarters. What is Climb Bio's EPS forecast for next year? Climb Bio's earnings are expected to grow from ($1.57) per share to ($0.66) per share in the next year. More Earnings Resources from MarketBeat Related Companies Rapport Therapeutics Earnings Results Amylyx Pharmaceuticals Earnings Results Tectonic Therapeutic Earnings Results Esperion Therapeutics Earnings Results Alpha Teknova Earnings Results Compass Therapeutics Earnings Results Atyr PHARMA Earnings Results Gossamer Bio Earnings Results Aquestive Therapeutics Earnings Results Cryoport Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Intuitive Machines Gains After Earnings Beat, NASA Missions AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio?Analysts Lift Archer Aviation Stock Despite Earnings Miss Remove Ads This page (NASDAQ:CLYM) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Climb Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Climb Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CLYM Stock Free CLYM Stock Alerts